{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T04:01:31Z","timestamp":1789704091995,"version":"4.0.1"},"reference-count":83,"publisher":"The Japanese Society for Neuroendovascular Therapy","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["NOUSHINKEI KEKKANNAI TIRYOU","JNET"],"published-print":{"date-parts":[[2025]]},"DOI":"10.5797\/jnet.ra.2024-0008","type":"journal-article","created":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T22:12:00Z","timestamp":1716243120000},"page":"n\/a","source":"Crossref","is-referenced-by-count":8,"title":["An Updated Review on the Pathogenesis of Brain Arteriovenous Malformations and Its Therapeutic Targets"],"prefix":"10.5797","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5108-6719","authenticated-orcid":false,"given":"Takahiro","family":"Ota","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Tokyo Metropolitan Tama Medical Center, Fuchu, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3804","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Rothbart D, Awad IA, Lee J, et al. Expression of angiogenic factors and structural proteins in central nervous system vascular malformations. <i>Neurosurgery<\/i> 1996; 38: 915\u2013925; discussion, 924\u2013925.","DOI":"10.1097\/00006123-199605000-00011"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Hashimoto T, Wen G, Lawton MT, et al. Abnormal expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in brain arteriovenous malformations. <i>Stroke<\/i> 2003; 34: 925\u2013931.","DOI":"10.1161\/01.STR.0000061888.71524.DF"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Winkler EA, Lu AY, Raygor KP, et al. Defective vascular signaling &amp; prospective therapeutic targets in brain arteriovenous malformations. <i>Neurochem Int<\/i> 2019; 126: 126\u2013138.","DOI":"10.1016\/j.neuint.2019.03.002"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Walker EJ, Su H, Shen F, et al. Arteriovenous malformation in the adult mouse brain resembling the human disease. <i>Ann Neurol<\/i> 2011; 69: 954\u2013962.","DOI":"10.1002\/ana.22348"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Walcott BP, Smith ER, Scott RM, et al. Pial arteriovenous fistulae in pediatric patients: associated syndromes and treatment outcome. <i>J Neurointerv Surg<\/i> 2013; 5: 10\u201314.","DOI":"10.1136\/neurintsurg-2011-010168"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Eerola I, Boon LM, Mulliken JB, et al. Capillary malformation-arteriovenous malformation, a new clinical and genetic disorder caused by RASA1 mutations. <i>Am J Hum Genet<\/i> 2003; 73: 1240\u20131249. [Epub ahead of print]","DOI":"10.1086\/379793"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Leblanc GG, Golanov E, Awad IA, et al. Biology of vascular malformations of the brain. <i>Stroke<\/i> 2009; 40: e694\u2013702.","DOI":"10.1161\/STROKEAHA.109.563692"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Vorbrodt AW, Dobrogowska DHTM, Tarnawski M. Immunogold study of interendothelial junction-associated and glucose transporter proteins during postnatal maturation of the mouse blood-brain barrier. <i>J Neurocytol<\/i> 2001; 30: 705\u2013716.","DOI":"10.1023\/A:1016581801188"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Chen Q, Jin M, Yang F, et al. Matrix metalloproteinases: inflammatory regulators of cell behaviors in vascular formation and remodeling. <i>Mediat Inflamm<\/i> 2013; 1\u201314.","DOI":"10.1155\/2013\/928315"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Eelen G, Treps L, Li X, et al. Basic and therapeutic aspects of angiogenesis updated. <i>Circ Res<\/i> 2020; 127: 310\u2013329.","DOI":"10.1161\/CIRCRESAHA.120.316851"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Rundhaug JE. Matrix metalloproteinases and angiogenesis. <i>J Cell Mol Med<\/i> 2005; 9: 267\u2013285.","DOI":"10.1111\/j.1582-4934.2005.tb00355.x"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Glading A, Han J, Stockton RA, et al. KRIT-1\/CCM1 is a Rap1 effector that regulates endothelial cell-cell junctions. <i>J Cell Biol<\/i> 2007; 179: 247\u2013254.","DOI":"10.1083\/jcb.200705175"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) McCormick WF. The pathology of vascular (\u201carteriovenous\u201d) malformations. <i>J Neurosurg1<\/i> 1966; 24: 807\u2013816.","DOI":"10.3171\/jns.1966.24.4.0807"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Winkler EA, Birk H, Burkhardt J-K, et al. Reductions in brain pericytes are associated with arteriovenous malformation vascular instability. <i>J Neurosurg<\/i> 2018; 129: 1464\u20131474.","DOI":"10.3171\/2017.6.JNS17860"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Abla AA, Nelson J, Kim H, et al. Silent arteriovenous malformation hemorrhage and the recognition of \u201cunruptured\u201d arteriovenous malformation patients who benefit from surgical intervention. <i>Neurosurgery<\/i> 2015; 76: 592\u2013600; discussion, 600.","DOI":"10.1227\/NEU.0000000000000686"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Kawasaki K, Watabe T, Sase H, et al. Ras signaling directs endothelial specification of VEGFR2+ vascular progenitor cells. <i>J Cell Biol<\/i> 2008; 181: 131\u2013141.","DOI":"10.1083\/jcb.200709127"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Ferreira R, Santos T, Amar A, et al. MicroRNA-18a improves human cerebral arteriovenous malformation endothelial cell function. <i>Stroke<\/i> 2014; 45: 293\u2013297.","DOI":"10.1161\/STROKEAHA.113.003578"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Komiyama M. Pathogenesis of brain arteriovenous malformations. <i>Neurol Med Chir (Tokyo)<\/i> 2016; 56: 317\u2013325.","DOI":"10.2176\/nmc.ra.2016-0051"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Nielsen CM, Huang L, Murphy PA, et al. Mouse models of cerebral arteriovenous malformation. <i>Stroke<\/i> 2016; 47: 293\u2013300.","DOI":"10.1161\/STROKEAHA.115.002869"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Chen W, Sun Z, Han Z, et al. De novo cerebrovascular malformation in the adult mouse after endothelial alk1 deletion and angiogenic stimulation. <i>Stroke<\/i> 2014; 45: 900\u2013902.","DOI":"10.1161\/STROKEAHA.113.003655"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Guo Y, Tihan T, Kim H, et al. Distinctive distribution of lymphocytes in unruptured and previously untreated brain arteriovenous malformation. <i>Neuroimmunol Neuroinflamm<\/i> 2014; 1: 147\u2013152.","DOI":"10.4103\/2347-8659.143674"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Zhu W, Chen W, Zou D, et al. Thalidomide reduces hemorrhage of brain arteriovenous malformations in a mouse model. <i>Stroke<\/i> 2018; 49: 1232\u20131240.","DOI":"10.1161\/STROKEAHA.117.020356"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Huang J, Song J, Qu M, et al. MicroRNA-137 and microRNA-195* inhibit vasculogenesis in brain arteriovenous malformations. <i>Ann Neurol<\/i> 2017; 82: 371\u2013384. [Epub ahead of print]","DOI":"10.1002\/ana.25015"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Chen W, Guo Y, Walker EJ, et al. Reduced mural cell coverage and impaired vessel integrity after angiogenic stimulation in the Alk1-deficient brain. <i>Arterioscler Thromb Vasc Biol<\/i> 2013; 33: 305\u2013310.","DOI":"10.1161\/ATVBAHA.112.300485"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Sun Z, Kemp SS, Lin PK, et al. Endothelial k-RasV12 expression induces capillary deficiency attributable to marked tube network expansion coupled to reduced pericytes and basement membranes. <i>Arterioscler Thromb Vasc Biol<\/i> 2022; 42: 205\u2013222.","DOI":"10.1161\/ATVBAHA.121.316798"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Pan P, Shaligram SS, Do Prado LB, et al. The role of mural cells in hemorrhage of brain arteriovenous malformation. <i>Brain Hemorrhages<\/i> 2021; 2: 49\u201356.","DOI":"10.1016\/j.hest.2020.10.005"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Hashimoto T, Lam T, Boudreau NJ, et al. Abnormal balance in the angiopoietin-Tie2 System in human brain arteriovenous malformations. <i>Circ Res<\/i> 2001; 89: 111\u2013113.","DOI":"10.1161\/hh1401.094281"},{"key":"28","unstructured":"28) Hashimoto T, Wu Y, Lawton MT, et al. Coexpression of angiogenic factors in brain arteriovenous malformations. <i>Neurosurgery<\/i> 2005; 56: 1058\u20131065; discussion, 1058\u20131065."},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Liu Q, Yang Y, Fan X. Microvascular pericytes in brain-associated vascular disease. <i>Biomed Pharmacother<\/i> 2020; 121: 109633.","DOI":"10.1016\/j.biopha.2019.109633"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Mouchtouris N, Jabbour PM, Starke RM, et al. Biology of cerebral arteriovenous malformations with a focus on inflammation. <i>J Cereb Blood Flow Metab<\/i> 2015; 35: 167\u2013175.","DOI":"10.1038\/jcbfm.2014.179"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Li X, Wang R, Wang X, et al. Relevance of IL-6 and MMP-9 to cerebral arteriovenous malformation and hemorrhage. <i>Mol Med Rep<\/i> 2013; 7: 1261\u20131266.","DOI":"10.3892\/mmr.2013.1332"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Y\u0131lmaz B, Toktas ZO, Akakin A, et al. Familial occurrence of brain arteriovenous malformation: a novel ACVRL1 mutation detected by whole exome sequencing. <i>J Neurosurg<\/i> 2017; 126: 1879\u20131883.","DOI":"10.3171\/2016.6.JNS16665"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Achrol A, Kim H, Pawlikowska L, et al. Association of tumor necrosis factor-\u03b1-238G&gt;A and apolipoprotein E2 polymorphisms with intracranial hemorrhage after brain arteriovenous malformation treatment. <i>Neurosurgery<\/i> 2007; 61: 731\u2013739, discussion, 740.","DOI":"10.1227\/01.NEU.0000298901.61849.A4"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Chen Y, Zhu W, Bollen AW, et al. Evidence of inflammatory cell involvement in brain arteriovenous malformations. <i>Neurosurgery<\/i> 2008; 62: 1340\u20131349; discussion, 1349\u20131350.","DOI":"10.1227\/01.neu.0000333306.64683.b5"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Walcott BP, Winkler EA, Zhou S, et al. Identification of a rare BMP pathway mutation in a non-syndromic human brain arteriovenous malformation via exome sequencing. <i>Hum Genome Var<\/i> 2018; 5: 18001.","DOI":"10.1038\/hgv.2018.1"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Koizumi T, Shiraishi T, Hagihara N, et al. Expression of vascular endothelial growth factors and their receptors in and around intracranial arteriovenous malformations. <i>Neurosurgery<\/i> 2002; 50: 117\u2013124; discussion, 124\u2013126.","DOI":"10.1227\/00006123-200201000-00020"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Wu CY, Wang YH, Meng FG, et al. Development of stereotactic neurosurgery in China. <i>Neurosurgery<\/i> 2005; 56: 851\u2013860; discussion, 851\u2013860. [Epub ahead of print]","DOI":"10.1227\/01.NEU.0000156618.10291.F2"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Lee CZ, Xue Z, Zhu Y, et al. Matrix metalloproteinase-9 inhibition attenuates vascular endothelial growth factor-induced intracerebral hemorrhage. <i>Stroke<\/i> 2007; 38: 2563\u20132568.","DOI":"10.1161\/STROKEAHA.106.481515"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Shaligram SS, Winkler E, Cooke D, et al. Risk factors for hemorrhage of brain arteriovenous malformation. <i>CNS Neurosci Ther<\/i> 2019; cns.13200.","DOI":"10.1111\/cns.13200"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Sweeney MD, Ayyadurai S, Zlokovic BV. Pericytes of the neurovascular unit: key functions and signaling pathways. <i>Nat Neurosci<\/i> 2016; 19: 771\u2013783.","DOI":"10.1038\/nn.4288"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Pawlikowska L, Tran MN, Achrol AS, et al. Polymorphisms in transforming growth factor-\u03b2-related genes ALK1 and ENG are associated with sporadic brain arteriovenous malformations. <i>Stroke<\/i> 2005; 36: 2278\u20132280.","DOI":"10.1161\/01.STR.0000182253.91167.fa"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Janes MR, Zhang J, Li L-S, et al. Targeting KRAS mutant cancers with a covalent G12C-specific inhibitor. <i>Cell<\/i> 2018; 172: 578\u2013589.e17.","DOI":"10.1016\/j.cell.2018.01.006"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Hill-Felberg S, Wu HH, Toms SA, et al. Notch receptor expression in human brain arteriovenous malformations. <i>J Cell Mol Med<\/i> 2015; 19: 1986\u20131993.","DOI":"10.1111\/jcmm.12580"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Thomas JM, Surendran S, Abraham M, et al. Gene expression analysis of nidus of cerebral arteriovenous malformations reveals vascular structures with deficient differentiation and maturation. <i>PLoS One<\/i> 2018; 13: e0198617. [Epub ahead of print]","DOI":"10.1371\/journal.pone.0198617"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Li S, Wang R, Wang Y, et al. Receptors of the Notch signaling pathway are associated with hemorrhage of brain arteriovenous malformations. <i>Mol Med Rep<\/i> 2014; 9: 2233\u20132238.","DOI":"10.3892\/mmr.2014.2061"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Delev D, Pavlova A, Grote A, et al. NOTCH4 gene polymorphisms as potential risk factors for brain arteriovenous malformation development and hemorrhagic presentation. <i>J Neurosurg<\/i> 2017; 126: 1552\u20131559.","DOI":"10.3171\/2016.3.JNS151731"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47) Nikolaev SI, Vetiska S, Bonilla X, et al. Somatic activating KRAS mutations in arteriovenous malformations of the brain. <i>N Engl J Med<\/i> 2018; 378: 250\u2013261.","DOI":"10.1056\/NEJMoa1709449"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48) Fish JE, Flores Suarez CP, Boudreau E, et al. Somatic gain of KRAS function in the endothelium is sufficient to cause vascular malformations that require MEK but not PI3K signaling. <i>Circ Res<\/i> 2020; 127: 727\u2013743.","DOI":"10.1161\/CIRCRESAHA.119.316500"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49) Peterson K, Coffman S, Zehri A, et al. Somatic mosaicism in the pathogenesis of de novo cerebral arteriovenous malformations: a paradigm shift implicating the RAS-MAPK signaling cascade. <i>Cerebrovasc Dis<\/i> 2021; 50: 231\u2013238.","DOI":"10.1159\/000512800"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50) Hong T, Yan Y, Li J, et al. High prevalence of KRAS\/BRAF somatic mutations in brain and spinal cord arteriovenous malformations. <i>Brain<\/i> 2019; 142: 23\u201334.","DOI":"10.1093\/brain\/awy307"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51) Oka M, Kushamae M, Aoki T, et al. KRAS G12D or G12V mutation in human brain arteriovenous malformations. <i>World Neurosurg<\/i> 2019; 126: e1365\u2013e1373.","DOI":"10.1016\/j.wneu.2019.03.105"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52) Al-Olabi L, Polubothu S, Dowsett K, et al. Mosaic RAS\/MAPK variants cause sporadic vascular malformations which respond to targeted therapy. <i>J Clin Invest<\/i> 2018; 128: 1496\u20131508.","DOI":"10.1172\/JCI98589"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53) Priemer DS, Vortmeyer AO, Zhang S, et al. Activating KRAS mutations in arteriovenous malformations of the brain: frequency and clinicopathologic correlation. <i>Hum Pathol<\/i> 2019; 89: 33\u201339.","DOI":"10.1016\/j.humpath.2019.04.004"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54) Papke B, Der CJ. Drugging RAS: know the enemy. <i>Science <\/i> 2017; 355: 1158\u20131163.","DOI":"10.1126\/science.aam7622"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55) Goss JA, Huang AY, Smith E, et al. Somatic mutations in intracranial arteriovenous malformations. <i>PLoS One<\/i> 2019; 14: e0226852.","DOI":"10.1371\/journal.pone.0226852"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56) Karpathiou G, Chauleur C, Da Cruz V, et al. Vascular lesions of the female genital tract: clinicopathologic findings and application of the ISSVA classification. <i>Pathophysiology<\/i> 2017; 24: 161\u2013167.","DOI":"10.1016\/j.pathophys.2017.04.002"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57) Venugopal V, Sumi S. Molecular biomarkers and drug targets in brain arteriovenous and cavernous malformations: where are we? <i>Stroke<\/i> 2022; 53: 279\u2013289.","DOI":"10.1161\/STROKEAHA.121.035654"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58) Shovlin CL. Hereditary haemorrhagic telangiectasia: pathophysiology, diagnosis and treatment. <i>Blood Rev<\/i> 2010; 24: 203\u2013219.","DOI":"10.1016\/j.blre.2010.07.001"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59) Govani FS, Shovlin CL. Hereditary haemorrhagic telangiectasia: a clinical and scientific review. <i>Eur J Hum Genet<\/i> 2009; 17: 860\u2013871.","DOI":"10.1038\/ejhg.2009.35"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60) Roman BL, Hinck AP. ALK1 signaling in development and disease: new paradigms. <i>Cell Mol Life Sci<\/i> 2017; 74: 4539\u20134560.","DOI":"10.1007\/s00018-017-2636-4"},{"key":"61","doi-asserted-by":"crossref","unstructured":"61) Gallione CJ, Richards JA, Letteboer TG, et al. SMAD4 mutations found in unselected HHT patients. <i>J Med Genet<\/i> 2006; 43: 793\u2013797.","DOI":"10.1136\/jmg.2006.041517"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62) Hwan Kim Y, Vu PN, Choe SW, et al. Overexpression of activin receptor-like kinase 1 in endothelial cells suppresses development of arteriovenous malformations in mouse models of hereditary hemorrhagic telangiectasia. <i>Circ Res<\/i> 2020; 127: 1122\u20131137.","DOI":"10.1161\/CIRCRESAHA.119.316267"},{"key":"63","doi-asserted-by":"crossref","unstructured":"63) Maher CO, Piepgras DG, Brown RD Jr, et al. Cerebrovascular manifestations in 321 cases of hereditary hemorrhagic telangiectasia. <i>Stroke<\/i> 2001; 32: 877\u2013882.","DOI":"10.1161\/01.STR.32.4.877"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64) Bharatha A, Faughnan ME, Kim H, et al. Brain arteriovenous malformation multiplicity predicts the diagnosis of hereditary hemorrhagic telangiectasia: Quantitative assessment. <i>Stroke<\/i> 2012; 43: 72\u201378.","DOI":"10.1161\/STROKEAHA.111.629865"},{"key":"65","doi-asserted-by":"crossref","unstructured":"65) Krings T, Kim H, Power S, et al. Neurovascular manifestations in hereditary hemorrhagic telangiectasia: imaging features and genotype-phenotype correlations. <i>AJNR Am J Neuroradiol<\/i> 2015; 36: 863\u2013870.","DOI":"10.3174\/ajnr.A4210"},{"key":"66","doi-asserted-by":"crossref","unstructured":"66) Brinjikji W, Iyer VN, Wood CP, et al. Prevalence and characteristics of brain arteriovenous malformations in hereditary hemorrhagic telangiectasia: a systematic review and meta-analysis. <i>J Neurosurg<\/i> 2017; 127: 302\u2013310.","DOI":"10.3171\/2016.7.JNS16847"},{"key":"67","doi-asserted-by":"crossref","unstructured":"67) Komiyama M, Terada A, Ishiguro T, et al. Neuroradiological manifestations of hereditary hemorrhagic telangiectasia in 139 Japanese patients. <i>Neurol Med Chir (Tokyo)<\/i> 2015; 55: 479\u2013486.","DOI":"10.2176\/nmc.oa.2015-0040"},{"key":"68","doi-asserted-by":"crossref","unstructured":"68) Nishida T, Faughnan M, Krings T, et al. Brain arteriovenous malformations associated with hereditary hemorrhagic telangiectasia: gene-phenotype correlations. <i>Am J Med Genet A<\/i> 2012; 158A: 2829\u20132834.","DOI":"10.1002\/ajmg.a.35622"},{"key":"69","doi-asserted-by":"crossref","unstructured":"69) Snellings DA, Gallione CJ, Clark DS, et al. Somatic mutations in vascular malformations of hereditary hemorrhagic telangiectasia result in biallelic loss of ENG or ACVRL1. <i>Am J Hum Genet<\/i> 2019; 105: 894\u2013906.","DOI":"10.1016\/j.ajhg.2019.09.010"},{"key":"70","doi-asserted-by":"crossref","unstructured":"70) Revencu N, Fastre E, Ravoet M, et al. RASA1 mosaic mutations in patients with capillary malformation-arteriovenous malformation. <i>J Med Genet<\/i> 2020; 57: 48\u201352.","DOI":"10.1136\/jmedgenet-2019-106024"},{"key":"71","doi-asserted-by":"crossref","unstructured":"71) Queisser A, Boon LM, Vikkula M. Etiology and genetics of congenital vascular lesions. <i>Otolaryngol Clin North Am<\/i> 2018; 51: 41\u201353.","DOI":"10.1016\/j.otc.2017.09.006"},{"key":"72","doi-asserted-by":"crossref","unstructured":"72) Maddy K, Chalamgari A, Ariwodo O, et al. An updated review on the genetics of arteriovenous malformations. <i>Gene Protein Dis<\/i> 2023; 2: 0312. [Epub ahead of print]","DOI":"10.36922\/gpd.0312"},{"key":"73","doi-asserted-by":"crossref","unstructured":"73) Barbosa Do Prado L, Han C, Oh SP, et al. Recent advances in basic research for brain arteriovenous malformation. <i>Int J Mol Sci<\/i> 2019; 20: 5324.","DOI":"10.3390\/ijms20215324"},{"key":"74","doi-asserted-by":"crossref","unstructured":"74) Iyer VN, Apala DR, Pannu BS, et al. Intravenous bevacizumab for refractory hereditary hemorrhagic telangiectasia-related epistaxis and gastro-intestinal bleeding. <i>Mayo Clin Proc<\/i> 2018; 93: 155\u2013166.","DOI":"10.1016\/j.mayocp.2017.11.013"},{"key":"75","doi-asserted-by":"crossref","unstructured":"75) Han C, Choe S, Kim YH, et al. VEGF neutralization can prevent and normalize arteriovenous malformations in an animal model for hereditary hemorrhagic telangiectasia 2. <i>Angiogenesis<\/i> 2014; 17: 823\u2013830.","DOI":"10.1007\/s10456-014-9436-3"},{"key":"76","doi-asserted-by":"crossref","unstructured":"76) Uysal E, Ba\u015fkurt O, Avc\u0131 \u0130, et al. Late recovery of stereotactic radiosurgery induced perilesional edema of an arteriovenous malformation after bevacizumab treatment. <i>Br J Neurosurg<\/i> 2021; 35: 22\u201326.","DOI":"10.1080\/02688697.2020.1742294"},{"key":"77","doi-asserted-by":"crossref","unstructured":"77) Buscarini E, Botella L, Geisthoff U, et al. Safety of thalidomide and bevacizumab in patients with hereditary hemorrhagic telangiectasia. <i>Orphanet J Rare Dis<\/i> 2019; 14: 28.","DOI":"10.1186\/s13023-018-0982-4"},{"key":"78","doi-asserted-by":"crossref","unstructured":"78) Walcott BP. BMP signaling modulation attenuates cerebral arteriovenous malformation formation in a vertebrate model. <i>J Cereb Blood Flow Metab<\/i> 2014; 34: 1688\u20131694.","DOI":"10.1038\/jcbfm.2014.134"},{"key":"79","doi-asserted-by":"crossref","unstructured":"79) Lebrin F, Srun S, Raymond K, et al. Thalidomide stimulates vessel maturation and reduces epistaxis in individuals with hereditary hemorrhagic telangiectasia. <i>Nat Med<\/i> 2010; 16: 420\u2013428.","DOI":"10.1038\/nm.2131"},{"key":"80","doi-asserted-by":"crossref","unstructured":"80) Starke RM, McCarthy D, Komotar RJ, et al. Somatic KRAS mutation found in sporadic arteriovenous malformations. <i>Neurosurgery<\/i> 2018; 83: E14\u2013E15.","DOI":"10.1093\/neuros\/nyy163"},{"key":"81","doi-asserted-by":"crossref","unstructured":"81) Lekwuttikarn R, Lim YH, Admani S, et al. Genotype-guided medical treatment of an arteriovenous malformation in a child. <i>JAMA Dermatol<\/i> 2019; 155: 256\u2013257.","DOI":"10.1001\/jamadermatol.2018.4653"},{"key":"82","doi-asserted-by":"crossref","unstructured":"82) Phung TL, Ziv K, Dabydeen D, et al. Pathological angiogenesis is induced by sustained Akt signaling and inhibited by rapamycin. <i>Cancer Cell<\/i> 2006; 10: 159\u2013170.","DOI":"10.1016\/j.ccr.2006.07.003"},{"key":"83","doi-asserted-by":"crossref","unstructured":"83) Chelliah MP, Do HM, Zinn Z, et al. Management of complex arteriovenous malformations using a novel combination therapeutic algorithm. <i>JAMA Dermatol<\/i> 2018; 154: 1316\u20131319.","DOI":"10.1001\/jamadermatol.2018.3039"}],"container-title":["Journal of Neuroendovascular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnet\/19\/1\/19_ra.2024-0008\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T04:19:43Z","timestamp":1738383583000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jnet\/19\/1\/19_ra.2024-0008\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":83,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.5797\/jnet.ra.2024-0008","relation":{},"ISSN":["1882-4072","2186-2494"],"issn-type":[{"value":"1882-4072","type":"print"},{"value":"2186-2494","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"ra.2024-0008"}}